Lindbrook Capital’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $2.72K | Hold |
164
| – | – | ﹤0.01% | 2190 |
|
|
2024
Q4 | $3.01K | Buy |
164
+38
| +30% | +$697 | ﹤0.01% | 2175 |
|
|
2024
Q3 | $1.94K | Buy |
126
+34
| +37% | +$523 | ﹤0.01% | 2355 |
|
|
2024
Q2 | $1.5K | Sell |
92
-19
| -17% | -$309 | ﹤0.01% | 2419 |
|
|
2024
Q1 | $2.05K | Buy |
111
+2
| +2% | +$37 | ﹤0.01% | 2228 |
|
|
2023
Q4 | $3.41K | Sell |
109
-23
| -17% | -$720 | ﹤0.01% | 2073 |
|
|
2023
Q3 | $2.75K | Buy |
132
+24
| +22% | +$500 | ﹤0.01% | 2008 |
|
|
2023
Q2 | $2.59K | Buy |
108
+16
| +17% | +$383 | ﹤0.01% | 2049 |
|
|
2023
Q1 | $1.73K | Hold |
92
| – | – | ﹤0.01% | 2302 |
|
|
2022
Q4 | $1.47K | Sell |
92
-304
| -77% | -$4.84K | ﹤0.01% | 2367 |
|
|
2022
Q3 | $6K | Buy |
396
+266
| +205% | +$4.03K | ﹤0.01% | 1537 |
|
|
2022
Q2 | $2K | Sell |
130
-37
| -22% | -$569 | ﹤0.01% | 1891 |
|
|
2022
Q1 | $4K | Buy |
167
+68
| +69% | +$1.63K | ﹤0.01% | 1661 |
|
|
2021
Q4 | $2K | Hold |
99
| – | – | ﹤0.01% | 1737 |
|
|
2021
Q3 | $2K | Buy |
+99
| New | +$2K | ﹤0.01% | 1487 |
|
|
2021
Q2 | – | Sell |
-65
| Closed | -$2K | – | 1899 |
|
|
2021
Q1 | $2K | Buy |
65
+53
| +442% | +$1.63K | ﹤0.01% | 1499 |
|
|
2020
Q4 | $1K | Buy |
+12
| New | +$1K | ﹤0.01% | 1555 |
|